Author

@DividendDynasty DividendDynasty

Transparent long-only GARP/quality-compounder accumulator who buys dips and never sells

Posts continuous real-time buy/add disclosures and valuation

trader score
+0.40
hit rate
45%
mean α
+0.19%
signals 14d
106

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 45% hit rate, +0.19% mean alpha, trader score +0.40. Their last-14d mentions, direction-adjusted, have moved +1.2% since posting (mean over 90 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16AVGO@DividendDynasty+0.90Predicts a generational AVGO run based on forecast EPS growth from FY25 to FY28.-2.2%
2026-10-16META@DividendDynasty+0.85Argues Meta's daily-user scale supports a valuation above $1,000 per share.-9.4%
2026-10-16AVGO@DividendDynasty+0.70Favors AVGO for its valuation, capital returns and growth outlook.-2.2%
2026-10-16MSFT@DividendDynasty+0.45Frames MSFT as potentially attractive based on its forward P/E and projected 2029 EPS.-0.9%
2026-10-15SPGI@DividendDynasty+0.85Discloses a long SPGI position and a multi-year bullish refinancing thesis.+6.0%
2026-10-15SPGI@DividendDynasty+0.20Recaps the day's positive portfolio contributors and progress toward a £50,000 milestone.+6.0%
2026-10-15NFLX@DividendDynasty+0.20Recaps the day's positive portfolio contributors and progress toward a £50,000 milestone.-9.3%
2026-10-15UBER@DividendDynasty+0.20Recaps the day's positive portfolio contributors and progress toward a £50,000 milestone.-6.4%
2026-10-15FICO@DividendDynasty+0.20Recaps the day's positive portfolio contributors and progress toward a £50,000 milestone.+5.9%
2026-10-15GRG.L@DividendDynasty+0.20Recaps the day's positive portfolio contributors and progress toward a £50,000 milestone.·
2026-10-15AVGO@DividendDynasty+0.65Labels AVGO undervalued and near multi-year lows.-6.6%
2026-10-15GRG.L@DividendDynasty+0.65Discloses dividend reinvestment and an 11.7% portfolio allocation to Greggs.·
2026-10-15MEDP@DividendDynasty-0.35Notes MEDP's exceptional past return but warns that growth is slowing and valuation is stretched.·
2026-10-15MCD@DividendDynasty+0.45Considering buying MCD today at an 18x forward P/E. — Plans to deploy new portfolio cash and explicitly identifies MCD as a current purchase candidate.+2.5%
2026-10-14MCD@DividendDynasty+0.45Views both ZETA growth and defensive MCD as strong buying opportunities.+4.3%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.